Hand-Foot Syndrome Prevention With Atorvastatin, PolyprenolHand-Foot Syndrome Prevention With Atorvastatin, Polyprenol
Breast cancer patients receiving capecitabine had a lower incidence of hand-foot syndrome after prophylactic treatment with atorvastatin and polyprenol. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 23, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Studies support broader use of cholesterol-lowering statins
The latest guidelines used to determine who should take a cholesterol-lowering statin to prevent heart disease appear to be more accurate and cost-efficient than the previous guidelines. That’s according to two studies led by Harvard researchers, both published in this week’s Journal of the American Medical Association.
For many years, the main deciding factor in who needed to take a statin was the level of an individual’s harmful low-density lipoprotein cholesterol (LDL). Updated guidelines published in 2013 by the American College of Cardiology and the American Heart Association moved away from LDL and ...
Source: New Harvard Health Information - July 16, 2015 Category: Consumer Health News Authors: Julie Corliss Tags: Drugs and Supplements cholesterol high cholesterol statins Source Type: news
Studies: Millions Could Benefit By Taking Cholesterol-Lowering Medications
BOSTON (CBS) — Millions more Americans could benefit from treatment with popular cholesterol-lowering medications, according to two new studies.
Nearly half of adults ages 40-to-75 might be eligible to take them.
Heart disease is still the number one killer of American men and women and cholesterol-lowering statins, like atorvastatin (Lipitor) and simvastatin (Zocor), have been shown to reduce heart disease in people at risk.
Before, doctors would treat patients primarily based on their cholesterol levels, but a couple of years ago, leading cardiologists urged doctors to treat patients based on their overall risk inc...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 15, 2015 Category: Consumer Health News Authors: mouellette2015 Tags: Health Healthwatch Heart Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Atorvastatin Dr. Mallika Marshall Health News Heart Disease Lipitor National Institutes Of Health Simvastatin Statins Zocor Source Type: news
Pfizer offers concessions to win EU okay for Hospira deal
(Reuters) — Pfizer (NYSE:PFE) offered concessions in a bid to win European Union regulatory approval for its $15 billion takeover of U.S. rival Hospira (NYSE:HSP), the European Commission said today.
The EU competition authority did not provide details of Pfizer’s proposal, in line with its policy. It extended the deadline for its decision to Aug. 4 from July 20 to examine the concessions.
It can either clear the deal, if it decides Pfizer has allayed competition concerns, or open a full-scale investigation.
Pfizer, maker of impotence treatment Viagra and cholesterol drug Lipitor, is making its biggest-ever acqui...
Source: Mass Device - July 14, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Hospital Care Mergers & Acquisitions Hospira Inc. Pfizer Inc. Source Type: news
4 million more prescriptions for Atorvastatin since 2013, figures show
This makes it the drug with the highest rise in number of items dispensed over the past yearRelated items from OnMedicaGP prescribing has increased by almost 60 per cent in a decadeNorth of England tops league table for overall GP prescription costsStatins and dietary changes have saved 20,000 livesUS doctor says FDA should have withdrawn rosuvastatinGPs defend practice on prescribing statins (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 7, 2015 Category: UK Health Source Type: news
Lipitor Lawsuit News: Newly-Released Joint Status Report Indicates...
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation, and the discovery currently underway in this proceeding will allow access to information that...(PRWeb June 27, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12815681.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 29, 2015 Category: Pharmaceuticals Source Type: news
Statin Drugs and Prostate Cancer
Statin drugs are a group of widely prescribed ones used to lower a person's cholesterol level. Common statin medications include brands such as Lipitor, Crestor and Zocar. Statins work by inhibiting an enzyme in the human body, 'HMG-CoA reductase,' which is used to manufacture cholesterol and the drugs may also help to clear already formed cholesterol from the bloodstream. High cholesterol is a known cause of cardiovascular disease and it is well-established that statins reduce the rate of illness and death caused by cardiovascular disease. While statins can help to prevent the risk of a stroke or heart attack, some studie...
Source: Disabled World - June 8, 2015 Category: Disability Tags: Pharmaceutical - Drug Information Source Type: news
Federal Court Overseeing Hundreds of Lipitor Lawsuits Prepares to...
Bernstein Liebhard LLP is representing plaintiffs in federal Lipitor lawsuits, and anticipates that the upcoming conference will address issues relevant to those cases.(PRWeb June 06, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12772196.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 7, 2015 Category: Pharmaceuticals Source Type: news
Do Statins Raise Lung Cancer Survival, Lower...
Do statin drugs like Lipitor increase lung cancer survival? What role might statins play in lung cancer prevention and lung cancer treatment? (Source: About.com Lung Cancer)
Source: About.com Lung Cancer - June 5, 2015 Category: Cancer & Oncology Authors: lungcancer.guide at about.com Tags: health Source Type: news
Progress of Federal Lipitor Lawsuits to Be Addressed During May Case...
Bernstein Liebhard is representing federal Lipitor lawsuit plaintiffs, all of whom allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin medication.(PRWeb May 17, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12727512.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 17, 2015 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuit News: Federal Court Issues New Order Allowing...
Bernstein Liebhard LLP is representing plaintiffs in federal Lipitor lawsuits that accuse Pfizer, Inc. of failing to warn patients about the alleged association between Lipitor and Type 2 diabetes.(PRWeb May 14, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12724124.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 15, 2015 Category: Pharmaceuticals Source Type: news
Federal Court Overseeing Hundreds of Lipitor Lawsuits Denies Defense...
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation, which involves thousands of cases alleging the statin medication increases a patient’s risk...(PRWeb April 29, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12690163.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 1, 2015 Category: Pharmaceuticals Source Type: news
Federal Lipitor Lawsuits Progress, as New Status Report Details...
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation who allege that Pfizer, Inc. failed to adequately warn patients that use of the statin...(PRWeb April 24, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-jury-trials/prweb12679569.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 25, 2015 Category: Pharmaceuticals Source Type: news
Lipitor Lawsuits Mount, as New Court Report Shows More Than 100...
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal proceeding established in District of South Carolina for product liability claims alleging the statin medication causes...(PRWeb April 19, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12664179.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 19, 2015 Category: Pharmaceuticals Source Type: news
Status of Federal Lipitor Lawsuits to Be Discussed During Case...
Bernstein Liebhard LLP is representing Lipitor Lawsuit plaintiffs in the federal proceeding, which involves allegations that the statin medication caused patients to develop new-onset Type 2 diabetes.(PRWeb April 05, 2015)Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12629737.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 6, 2015 Category: Pharmaceuticals Source Type: news
